Rapid test for detection of SARS-CoV-2 Antigen in human nasopharyngeal swab specimens (COVIRAT )
- UID
- MFG/IVD/2020/000130_62321ebb6bdf0b10635026041d2a303f_6992628a8a332de9ac2d6393992b7250
- Device class
- Class C
- Brand name
- Paracheck Pf Device
- Approving authority
- CDSCO -North Zone, Ghaziabad
- Product information
- Covirat is an invitro, rapid, qualitative immunoassay for the detection of nucleocapsid protein antigens expressed by the SARS-CoV-2 virus present in human nasopharyngeal swab specimens. It is to be used for screening or to aid in the diagnosis of COVID-19 disease. This rapid antigen detection test takes 15-30 minutes for producing a positive or negative test result. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Presumptive positive or negative result may need to be further confirmed with a molecular test.
Rapid test for detection of SARS-CoV-2 Antigen in human nasopharyngeal swab specimens (COVIRAT ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000130_62321ebb6bdf0b10635026041d2a303f_6992628a8a332de9ac2d6393992b7250. This device is marketed under the brand name Paracheck Pf Device. The license holder is VIOLA DIAGNOSTIC SYSTEMS - A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED,, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.